Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Aug;64(2):392-7.
doi: 10.1172/JCI109474.

Subset derivation of T-cell acute lymphoblastic leukemia in man

Subset derivation of T-cell acute lymphoblastic leukemia in man

E L Reinherz et al. J Clin Invest. 1979 Aug.

Abstract

Normal human peripheral blood T cells can be characterized as belonging to either the TH+2 or TH-2 T-cell subset. Approximately 20% of T cells are TH+2, whereas 80% are TH-2 utilizing specific heteroantisera. To determine shether human T-cell acute lymphoblastic leukemia (T-ALL) cells belong to one or another T-cell subset, cell surface phenotyping was performed on tumor populations from 25 patients with T-ALL. Tmuor cells from these 25 individuals were either TH+1 or TH-2, but not both. 5 of 25 patients had TH+2 T-ALL cells. These TH+2 tumor populations were found exclusively in children and often without an accompanying thymic mass. TH-2 T-ALL, in contrast, occurred in both children and adults and was almost always associated with thymic enlargement. Although children with TH+2 T-ALL had as high or higher peripheral blast counts on presentation than their TH-2 T-ALL counterparts, overall survival was greater for the TH+2 group (greater than 36 mo) than the TH-2 group (less than 12 mo). These studies demonstrate that T-cell leukemias in man arise from distinct T-cell subsets and that cell surface characterization of T-cell malignancies may provide useful clinical data related to prognosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1979 Apr;122(4):1335-41 - PubMed
    1. Blood. 1978 Sep;52(3):481-92 - PubMed
    1. J Immunol. 1978 Apr;120(4):1423-8 - PubMed
    1. J Immunol. 1978 Apr;120(4):1278-82 - PubMed
    1. J Exp Med. 1977 Jan 1;145(1):221-33 - PubMed

Publication types